-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Icecure Medical, Lowers Price Target to $2

Benzinga·08/15/2025 11:39:19
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $2.5 to $2.